Hostname: page-component-6bf8c574d5-8gtf8 Total loading time: 0 Render date: 2025-02-21T06:19:49.308Z Has data issue: false hasContentIssue false

Reduction in abdominal hysterectomy surgical site infection rates after the addition of anaerobic antimicrobial prophylaxis

Published online by Cambridge University Press:  28 August 2020

Takaaki Kobayashi*
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Kyle E. Jenn
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Noelle Bowdler
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Rita Malloy
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Stephanie Holley
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Tatiana Izakovic
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Mary E. Kukla
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Oluchi Abosi
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Angelique Dains
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Holly Meacham
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Daniel J. Diekema
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Michael B. Edmond
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
Jorge L. Salinas
Affiliation:
University of Iowa Hospitals & Clinics, Iowa City, Iowa
*
Author for correspondence: Takaaki Kobayashi, E-mail: Takaaki-kobayashi@uiowa.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
Research Brief
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Antimicrobial prophylaxis is one of the most effective surgical site infection (SSI) prevention measures.Reference Berrios-Torres, Umscheid and Bratzler1 Current guidelines recommend the use of cefazolin as prophylaxis for abdominal hysterectomy procedures.Reference Van Eyk, van Schalkwyk and Infectious Diseases2 However, there is growing evidence that anaerobes play a role in abdominal hysterectomy SSIs.Reference Till, Morgan and Bazzi3 We assessed the impact of adding anaerobic coverage on abdominal hysterectomy SSI rates in our institution.

Methods

The University of Iowa Hospitals & Clinics (UIHC) is an 811-bed academic medical center that serves as a referral center for Iowa. Historically, patients undergoing abdominal hysterectomy (open, laparoscopic, and robot-assisted laparoscopic) received only cefazolin for antimicrobial prophylaxis. However, in November 2017, patients undergoing abdominal hysterectomy began receiving metronidazole in addition to cefazolin after we noted an increase in SSI rates. Also, standardized infection ratios calculated by the National Healthcare Safety Network (NHSN) were >1. Order sets within the electronic health record were modified, and education was provided to surgeons, anesthesiologists, and other team members. SSI rates were calculated for abdominal hysterectomies undertaken between January 2015 and September 2019, using NHSN definitions. We excluded cases of vaginal hysterectomy. Rates were calculated for complex infections (deep incisional and organ space), and for infections at all depths (superficial incisional, deep incisional, and organ space). SSI rates were also investigated according the approach of the procedure (open vs minimally invasive surgery). Culture results were recorded. We conducted an interrupted time-series analysis using Stata software (StataCorp, College Station, TX) to determine the impact of adding prophylactic metronidazole on complex and all-depth abdominal hysterectomy SSI rates. Other prevention activities already in place included providing surgeons with individualized SSI data on a regular basis and real-time performance feedback as needed, as well as auditing compliance with preoperative chlorhexidine bathing.

Results

From January 2015 through September 2019, 3005 abdominal hysterectomies were performed at UIHC. We observed a significant decrease in the complex SSI rate from 1.5% (24 of 1,638) before to 0.6% (8 of 1,367) after adding prophylactic metronidazole (P = .01) (Fig. 1). We detected a nonsignificant decrease in the all-depth SSI rate from 3.2% (52 of 1,638) before to 1.6% (22 of 1,367) after the change in prophylaxis (P = .73). The proportion of open hysterectomies decreased from 59% to 33%, and minimally invasive hysterectomies increased proportionately during the study period. SSI rates decreased from 3.6% to 2.3% with open surgical approaches and from 2.4% to 0.8% with minimally invasive surgery (Table 1).

Abbreviations: m, month.

Fig. 1. Complex surgical site infections after abdominal hysterectomy, University of Iowa Hospitals and Clinics, 2015–2019.

Table 1. Surgical Site Infection Rates and Standardized Infection Ratios Before and After the Addition of Metronidazole Stratified by Surgical Approach, University of Iowa Hospitals and Clinics, 2015–2019

Note. SSI, surgical site infection, SIR, standardized infection ratios; MIS, minimally invasive surgery.

Pathogens were identified for 25 patients. The most common pathogen was Bacteroides spp (40%), followed by Escherichia coli (24%). After adding metronidazole, the proportion of positive cultures with anaerobes decreased from 82% to 50% among complex SSIs and from 59% to 25% among all depth SSIs.

Discussion

We compared the incidence of SSIs before and after adding anaerobic coverage to antimicrobial prophylaxis for abdominal hysterectomy. The addition of metronidazole was associated with a decrease in the abdominal hysterectomy complex SSI rate.

Postoperative infection remains one of the most common complications of surgical procedures in gynecology. The development of SSIs results in great patient morbidity.Reference Lefebvre, Allaire and Jeffrey4 Current antimicrobial prophylaxis guidelines recommend the use of cefazolin, cefotetan, cefoxitin, or ampicillin/sulbactam as a single agent before vaginal or abdominal hysterectomy.Reference Bratzler, Dellinger and Olsen5 The American College of Obstetricians and Gynecologists also recommends cefazolin.6 The widespread implementation of antibiotic prophylaxis prior to surgery, and the recognition of modifiable risk factors, has led to a reduction in SSIs in recent years. According to NHSN data for 2006 to 2008, the incidence of all-depth SSIs after abdominal hysterectomy was 2.7%.Reference Edwards, Peterson and Mu7 A more recent study from the Michigan Surgical Quality Collaboration cohort demonstrated an all-depth SSI rate of ~2.0%.Reference Morgan, Swenson and Streifel8,Reference Uppal, Harris and Al-Niaimi9 Uppal et alReference Uppal, Harris and Al-Niaimi9 revealed that the SSI rate was 1.8% with prophylaxis with a β-lactam, compared to 3.1% with β-lactam alternatives and 3.7% with nonstandard prophylaxis.Reference Uppal, Harris and Al-Niaimi9 The rate of SSI at our institution decreased from 3.2% to 1.6% after adding metronidazole to cefazolin for SSI prevention. A recent large retrospective study with 18,255 hysterectomies by Till et alReference Till, Morgan and Bazzi3 demonstrated that the risk of SSI was lower, at 1.4%, for patients who received cefazolin and metronidazole, compared to 1.8% with cefazolin alone, and this rate was 2.1% with a second-generation cephalosporin. Currently, no published prospective studies comparing cefazolin and metronidazole to cefazolin alone are available.

Cefazolin, a first-generation cephalosporin, is the most widely used preoperative antibiotic. However, organisms isolated from SSIs after abdominal hysterectomy include anaerobic vaginal flora, most commonly Bacteroides spp, Prevotella spp, Peptostreptococcus spp, and Gardnerella spp.Reference Soper, Bump and Hurt10 In our study, the most common organisms were Bacteroides spp. Although anaerobic coverage is recommended as prophylaxis for colorectal surgery,Reference Nelson, Glenny and Song11 its role has not been proven for abdominal hysterectomy. Some institutions have shifted to using second-generation cephalosporins to improve anaerobic coverage. However, resistance of Bacteroides spp to second-generation cephalosporins is 15%–25%.Reference Aldridge and Sanders12 Our study showed similar results to Till et alReference Till, Morgan and Bazzi3 in complex SSIs. Although all-depth SSI rates trended downward compared to before the implementation of metronidazole, the difference was not statistically significant at our institution. The lack of difference in all-depth SSI after the addition of metronidazole might be because microorganisms associated with superficial infections do not typically include anaerobes. However, given that deep infections are more serious than superficial infections, the impact of adding metronidazole to cefazolin is promising and should be further investigated.

This study has several imitations. It was conducted at a single center and the results may not be generalizable to other institutions. We did not compare differences in baseline characteristics. Comorbidities such as malignancy, obesity, and diabetes mellitus might have affected the development of SSI. However, we calculated the standardized infection ratios according to the NHSN guidelines, which account for such potential confounders, and we were still able to show a decrease in SIRs (Table 1). We only investigated the association between prophylaxis and SSI rates; we did not evaluate postoperative course or mortality. The reduction could have been affected due to the change of procedure approaches over the study period. However, the SSI rates decreased for both surgical approaches. Other SSI prevention activities already ongoing might have affected the reduction. Finally, change of surgeons over the study period could have affected the SSI rate.

In conclusion, hospitals should assess the microbiology of abdominal hysterectomy SSIs and could consider adding metronidazole to their antimicrobial prophylaxis if the rate of anaerobic infections is high.

References

Berrios-Torres, SI, Umscheid, CA, Bratzler, DW, et al. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 2017;152:784791.CrossRefGoogle ScholarPubMed
Van Eyk, N, van Schalkwyk, J, Infectious Diseases, C. Antibiotic prophylaxis in gynaecologic procedures. J Obstet Gynaecol Can 2012;34:382391.Google ScholarPubMed
Till, SR, Morgan, DM, Bazzi, AA, et al. Reducing surgical site infections after hysterectomy: metronidazole plus cefazolin compared with cephalosporin alone. Am J Obstet Gynecol 2017;217:187e1e11.Google ScholarPubMed
Lefebvre, G, Allaire, C, Jeffrey, J, Vilos G. No. 109–Hysterectomy. J Obstet Gynaecol Can 2018;40:e567e579.Google ScholarPubMed
Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195283.CrossRefGoogle ScholarPubMed
ACOG Practice Bulletin No. 195: Prevention of infection after gynecologic procedures. Obstet Gynecol 2018;131:e172e189.Google Scholar
Edwards, JR, Peterson, KD, Mu, Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783805.Google ScholarPubMed
Morgan, DM, Swenson, CW, Streifel, KM, et al. Surgical site infection following hysterectomy: adjusted rankings in a regional collaborative. Am J Obstet Gynecol 2016;214:259e1e8.Google Scholar
Uppal, S, Harris, J, Al-Niaimi, A, et al. Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy. Obstet Gynecol 2016;127:321329.CrossRefGoogle ScholarPubMed
Soper, DE, Bump, RC, Hurt, WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163:10161021.CrossRefGoogle ScholarPubMed
Nelson, RL, Glenny, AM, Song, F. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Revs 2009;1: CD001181.CrossRefGoogle Scholar
Aldridge, KE, Sanders, CV. Susceptibility trending of blood isolates of the Bacteroides fragilis group over a 12-year period to clindamycin, ampicillin-sulbactam, cefoxitin, imipenem, and metronidazole. Anaerobe 2002;8:301305.Google Scholar
Figure 0

Fig. 1. Complex surgical site infections after abdominal hysterectomy, University of Iowa Hospitals and Clinics, 2015–2019.

Abbreviations: m, month.
Figure 1

Table 1. Surgical Site Infection Rates and Standardized Infection Ratios Before and After the Addition of Metronidazole Stratified by Surgical Approach, University of Iowa Hospitals and Clinics, 2015–2019